Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
QS

Qing Shi — 26 Patents

Eli Lilly: 17 patents #167 of 2,858Top 6%
Bristol-Myers Squibb: 9 patents #586 of 3,969Top 15%
EPElan Pharmaceuticals: 5 patents #59 of 269Top 25%
ANAthena Neurosciences: 1 patents #49 of 81Top 65%
Princeton, NJ: #168 of 2,186 inventorsTop 8%
New Jersey: #2,828 of 69,400 inventorsTop 5%
Overall (All Time): #150,017 of 4,157,543Top 4%
26 Patents All Time
Qing Shi has been granted 26 US patents while listed as an inventor at Eli Lilly. The first was granted in 2003 and the most recent in September 2022. Qing Shi ranks #150,017 of 4,157,543 US inventors in our database (top 3.6%). Patent records list Qing Shi in Princeton, NJ, US.

Patents per Year

Patents granted per year, 2003 to 2022Bar chart with a peak of 3 patents in 2003.peak 32003: 3 patents20032004: 1 patents2005: 2 patents20052007: 2 patents2011: 2 patents20112012: 3 patents2013: 2 patents20132016: 1 patents2017: 2 patents20172018: 3 patents2019: 2 patents20192021: 1 patents2022: 2 patents2022

Issued Patents All Time

Showing 1–25 of 26 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11453673 Substituted [1,2,4]triazolo[4,3-a]pyrazines as phosphodiesterase inhibitors Nicholas Paul Camp, Chafiq Hamdouchi, Jayana Pankaj Lineswala, John Richard Morphy 2022-09-27 $750,369,000
11401274 [1,2,4]Triazolo derivatives as PDE1 inhibitors for the treatment of diabetes Michael James Genin, William Glen Holloway, Cynthia Darshini Jesudason 2022-08-02 $1,780,908,000
11180503 [1,2,4]Triazolo[4,3-A]pyrazin-6(5H)-one derivatives Michael James Genin, William Glen Holloway, Richard Duane Johnston, John Richard Morphy 2021-11-23 $939,663,000
10435415 Substituted tetrahydrocarbazole and carbazole carboxamide compounds Douglas G. Batt, Myra Beaudoin Bertrand, George V. De Lucca, Michael Galella, Soo S. Ko +5 more 2019-10-08
10214537 Bicyclic heteroaryl amine compounds Rajeev S. Bhide, Douglas G. Batt, Robert J. Cherney, Lyndon A. M. Cornelius, Qingjie Liu +8 more 2019-02-26
10138244 Triazolopyrazinone derivative useful as a human PDE1 inhibitor Mark David Rekhter 2018-11-27 $565,573,000
10106559 Substituted tetrahydrocarbazole and carbazole carboxamide compounds Douglas G. Batt, Myra Beaudoin Bertrand, George V. DeLucca, Michael Galella, Soo S. Ko +5 more 2018-10-23
10023576 Heteroaryl substituted pyrrolotriazine amine compounds as PI3K inhibitors Rajeev S. Bhide, Zheming Ruan, Robert J. Cherney, Lyndon A. M. Cornelius, T. G. Murali Dhar +5 more 2018-07-17
9815859 Tricyclic sulfones as RORγ modulators Jingwu Duan, T. G. Murali Dhar, David Marcoux, Douglas G. Batt, Qingjie Liu +5 more 2017-11-14
9637495 CGRP receptor antagonists David Coates, Kevin Charles FORTNER, Richard Duane Johnston, Steven Marc Massey, Jason K. Myers +1 more 2017-05-02 $234,079,000
9334290 Substituted tetrahydrocarbazole and carbazole carboxamide compounds Douglas G. Batt, Myra Beaudoin Bertrand, George V. DeLucca, Michael Galella, Soo S. Ko +5 more 2016-05-10
8586751 Nicotinamide compounds useful as kinase modulators George V. De Lucca, Chunjian Liu, Jingwu Duan, Andrew J. Tebben 2013-11-19 $194,958,000
8362065 Carbazole carboxamide compounds useful as kinase inhibitors Qingjie Liu, Douglas G. Batt, George V. DeLucca, Andrew J. Tebben 2013-01-29 $45,866,000
8299061 Inhibitors of diacylglycerol acyltransferase Macklin Brian Arnold, Thomas Beauchamp, Emily J. Canada, Erik James Hembre, Jianliang Lu +2 more 2012-10-30
8133907 Pyridine derivatives as dipeptedyl peptidase inhibitors Larry C. Blaszczak, Brian Michael Mathes, Shon Pulley, Michael Alan Robertson, Scott Martin Sheehan +2 more 2012-03-13 $193,239,000
8106090 1-amino linked compounds Larry C. Blaszczak, Shon Pulley, Michael Alan Robertson, Scott Martin Sheehan, Michael Robert Wiley 2012-01-31 $97,135,000
8084620 Carbazole carboxamide compounds useful as kinase inhibitors Qingjie Liu, Douglas G. Batt, George V. DeLucca, Andrew J. Tebben 2011-12-27 $134,492,000
8076514 Phenyl compounds and their use in the treatment of Type II diabetes Larry C. Blaszczak, Shon Pulley, Michael Alan Robertson, Scott Martin Sheehan, Brian Morgan Watson +1 more 2011-12-13 $77,945,000
7291619 Melanocortin receptor agonists Christopher Kelly Biggers, Karin Briner, Christopher William Doecke, Matthew Joseph Fisher, Larry W. Hertel +8 more 2007-11-06 $65,050,000
7186715 Piperazine- and piperidine-derivatives as melanocortin receptor agonists Karin Briner, Christopher William Doecke, Vincent Mancuso, Michael John Martinelli, Timothy Ivo Richardson +2 more 2007-03-06 $170,937,000
6906056 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds Richard Thompson, Stephen Wilkie, Douglas Richard Stack, Eldon Vanmeter, Thomas C. Britton +9 more 2005-06-14 $111,693,000
6838455 Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds James E. Audia, Warren J. Porter, Richard Thompson, Stephen Wilkie, Douglas Richard Stack 2005-01-04 $316,880,000
6696438 Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds James E. Audia, Bruce A. Dressman 2004-02-24 $236,890,000
6569851 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds Richard Thompson, Stephen Wilkie, Douglas Richard Stack, Eldon Vanmeter, Thomas C. Britton +9 more 2003-05-27 $145,984,000
6552013 Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds James E. Audia, Warren J. Porter, Richard Thompson, Stephen Wilkie, Douglas Richard Stack 2003-04-22 $103,002,000